Tg Therapeutics, Inc. · NASDAQ:TGTX
Tg Therapeutics, Inc. shareholders
As of Jun 30, 2026, 418 institutions reported holding Tg Therapeutics, Inc., 72.6% of its shares. Largest: BlackRock, Vanguard and State Street. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Tg Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| BlackRock | 22.1M | 14.4% | −203K | Aug 7, 2026 |
| Vanguard | 15.3M | 10.0% | −769K | Aug 13, 2026 |
| State Street | 7.79M | 5.1% | −863K | Aug 7, 2026 |
| Geode Capital | 3.64M | 2.4% | +142K | Aug 12, 2026 |
| D. E. Shaw & Co., Inc. | 3.4M | 2.2% | +2.81M | Aug 14, 2026 |
| Soleus Capital Management, L.P. | 2.93M | 1.9% | −1.1M | Aug 11, 2026 |
| T. Rowe Price | 2.77M | 1.8% | +2.13M | Aug 14, 2026 |
| Franklin Templeton | 2.72M | 1.8% | −576K | Aug 13, 2026 |
| Congress Asset Management Co | 2.6M | 1.7% | +432K | Jul 7, 2026 |
| Two Sigma | 2.47M | 1.6% | +927K | Aug 14, 2026 |